Trade Benitec Biopharma Inc. - BNTC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0642 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.5329 |
| Open | 6.4729 |
| 1-Year Change | 3138.07% |
| Day's Range | 6.4729 - 6.8529 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | 6.8429 | 0.3700 | 5.72% | 6.4729 | 6.8729 | 6.4629 |
| Apr 24, 2024 | 6.5329 | -0.1100 | -1.66% | 6.6429 | 6.9829 | 6.3929 |
| Apr 23, 2024 | 6.8429 | 0.4500 | 7.04% | 6.3929 | 6.9029 | 6.3829 |
| Apr 22, 2024 | 6.7129 | -0.3900 | -5.49% | 7.1029 | 7.2429 | 6.4729 |
| Apr 19, 2024 | 6.8029 | -0.0300 | -0.44% | 6.8329 | 7.0529 | 6.3429 |
| Apr 18, 2024 | 6.8529 | 1.6100 | 30.71% | 5.2429 | 7.3929 | 5.0729 |
| Apr 17, 2024 | 4.7929 | 0.0000 | 0.00% | 4.7929 | 4.8929 | 4.7129 |
| Apr 16, 2024 | 4.7429 | 0.0300 | 0.64% | 4.7129 | 4.8429 | 4.5629 |
| Apr 15, 2024 | 4.7429 | -0.4400 | -8.49% | 5.1829 | 5.4729 | 4.6429 |
| Apr 12, 2024 | 5.3929 | -0.4200 | -7.23% | 5.8129 | 6.1829 | 5.1829 |
| Apr 11, 2024 | 6.1229 | 0.5500 | 9.87% | 5.5729 | 6.2329 | 5.5729 |
| Apr 10, 2024 | 5.9429 | 0.3600 | 6.45% | 5.5829 | 5.9429 | 5.5129 |
| Apr 9, 2024 | 5.8929 | 0.5200 | 9.68% | 5.3729 | 5.8929 | 5.3329 |
| Apr 8, 2024 | 5.5929 | 0.2400 | 4.48% | 5.3529 | 5.5929 | 5.3529 |
| Apr 5, 2024 | 5.4529 | 0.1200 | 2.25% | 5.3329 | 5.4729 | 5.3329 |
| Apr 4, 2024 | 5.4129 | -0.0800 | -1.46% | 5.4929 | 5.6029 | 5.2729 |
| Apr 3, 2024 | 5.4829 | 0.4500 | 8.94% | 5.0329 | 5.6929 | 5.0329 |
| Apr 2, 2024 | 5.1329 | 0.1000 | 1.99% | 5.0329 | 5.3029 | 5.0329 |
| Apr 1, 2024 | 5.0829 | -0.0300 | -0.59% | 5.1129 | 5.3229 | 5.0329 |
| Mar 28, 2024 | 5.0929 | -0.0500 | -0.97% | 5.1429 | 5.1429 | 4.9729 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Benitec Biopharma Inc. Company profile
About Benitec Biopharma Inc
Benitec Biopharma Inc is an Australia-based biotechnology company. The Company is focused on developing a therapeutic technology platform that combines ribonucleic acid (RNA) interference with gene therapy for the goal of silencing disease-causing genes from a single administration. The Company's technology, deoxyribonucleic acid (DNA)-directed RNA interference (ddRNAi), is used to develop product candidates in chronic and life-threatening human disease areas including orphan disease and infectious disease. Its pipeline includes BB-301, and BB-103. The Company's lead product candidate, BB-301, is used for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD). Its BB-103 pipeline product is being developed for the treatment of chronic hepatitis B Virus infection.
Financial summary
BRIEF: For the six months ended 31 December 2021, Benitec Biopharma Inc revenues decreased 55% to $25K. Net loss increased 65% to $9.9M. Revenues reflect Licensing revenue segment decrease from $56K to $0K. Higher net loss reflects Research and development - Balancing val increase from $1.9M to $5.8M (expense), Stock-based Compensation in SGA increase from $105K to $349K (expense).
Equity composition
FY'05 is being restated for change in reporting GAAP to IFRS.04/2009, Rights Issue, 1 new share for every 3.142 shares held @ AUD .03 (Factor:1.000000). 04/2011, Rights Issue, 4 new shares for every 5 shares held @ AUD 0.02 (Factor:1.235330). 07/2013, 1-for-25 Reverse Stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
3940 Trust Way
HAYWARD
CALIFORNIA 94545
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com